EMVision Medical Devices Limited provided an update on its clinical trial. The pre-validation phase of the clinical trial is tracking well, with all 30 participants for Stage 1 (healthy volunteers) having now been successfully enrolled and scanned at Liverpool Hospital. Each healthy baseline volunteer received a scan with the EMVision 1st Generation portable brain scanner alongside an MRI.

The full dataset, once received, will be processed and analysed, however early indications from an engineering review of an initial cohort are promising, with high quality signals, that are stable and consistent, having been obtained from the EMVision 1st Gen scanner for the healthy baseline scans. The hardware is performing as designed and the participant data, alongside ground truth segmented MRIs from the company's core imaging lab, is being used to advance EMVision's Artificial Intelligence algorithms and other imaging techniques. Preparations, including product enhancements from Stage 1, are now underway to enable Stage 2 of pre-validation phase to shortly be activated.

Stage 2 will enrol up to 150 acute stroke and stroke mimic patients across leading comprehensive stroke centres including Liverpool Hospital, Royal Melbourne Hospital and Princess Alexandra Hospital in Brisbane.